Goldman Sachs analyst Bonnie Herzog raised the firm’s price target on Colgate-Palmolive (CL) to $100 from $94 and keeps a Buy rating on the shares. The firm has come away from the management’s presentation incrementally positive, believing that a combination of steps that Colgate-Palmolive is taking as part of SGPP and its 2030 strategic plan, along with its favorable emerging market exposure, innovation launches, easing compares and a lower drag from private label pet food exit should support a sequential acceleration of growth in FY26, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- TheStreet Pro Analysts Say, “It’s a Stock Picker’s Market – Here Are 4 to Consider”
- Colgate-Palmolive price target raised to $100 from $94 at Wells Fargo
- Colgate-Palmolive target raised to $93 from $84 at Rothschild & Co Redburn
- Colgate-Palmolive CEO Wallace sells $4.28M of common shares
- Colgate-Palmolive price target raised to $88 from $83 at Barclays
